1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.

Lupin Ltd.

NSE: LUPIN | BSE: 500257

Download real time

2034.65 42.80 (2.15%)

36.25% Gain from 52W Low

548.4K NSE+BSE Volume

NSE 18 Mar, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
21S
4W
8O
2T
92,890.1

Market Cap

High in industry
32.4

PE TTM

Below industry Median
0.5

PEG TTM

PEG TTM is less than 1
5.9

Price to Book

Above industry Median
0.6

Beta 1Year

Very Low volatility
US FDA Approval
Lupin gets US FDA tentative approval for Amifampridine tablets, with a market size of $306 million See details


Lupin Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lupin Ltd. on BSE

announcement
Get corporate announcements alerts
Load latest
Is Lupin Ltd. worth buying?
907 Votes:
Buy 72.66%
Sell 17.64%
Hold 9.7%
BUY
SELL
HOLD
Hold SEE REPORTS >
13 Mar 2025
Lupin Ltd.
by Geojit BNP Paribas | Target: 2132 | Upside: 4.78%
Buy SEE REPORTS >
13 Feb 2025
Lupin Ltd.
by KRChoksey | Target: 2472 | Upside: 21.50%
All reports of LUPIN